Q/LAIV (Quadrivalent Live Attenuated Influenza Vaccine)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Q/LAIV (Quadrivalent Live Attenuated Influenza Vaccine), covering 2016-09-07 to 2016-09-07. Get the full timeline:
Most recent: Clinical Trial Update: Postmarketing Safety Study of Q/LAIV in Subjects 2 Through 49 Years of Age